Status | Study |
Recruiting |
Study Name: Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension Condition: Scleroderma, Diffuse Scleroderma, Systemic Date: 2016-02-08 Interventions: Drug: Oral Ifetroban Subjects |
Withdrawn |
Study Name: Systemic Sclerosis Clinical and Biomarker Study Condition: Healthy Systemic Sclerosis Date: 2015-08-20 |
Terminated |
Study Name: Exparel as a Nerve Block for Severe Hand Pain Condition: CREST Syndrome Peripheral Vascular Disease Raynaud Disease Date: 2015-02-23 Interventions: Drug: liposomal bupivacaine injected as an axillary block |
Completed |
Study Name: A Non-Interventional Pilot Study Assessing Whether Lysyl Oxidase-like 2 (LOXL2) is Present in Subjects With Scleroderma Condition: Limited Scleroderma Diffuse Scleroderma Date: 2013-06-05 |
Completed |
Study Name: Effect of Sildenafil on the Microcirculatory Blood Flow and Endothelial Progenitor Cells in Systemic Sclerosis Condition: Scleroderma, Systemic Scleroderma, Diffuse Date: 2011-05-02 Interventions: Drug: Sildenafil citrate Oral |
Terminated |
Study Name: Transversalis Fascial Plane Nerve Block in Iliac Crest Bone Graft Condition: Upper Limb Surgery Iliac Crest Bone Harvest Date: 2010-05-27 Interventions: Drug: Active treatment US-guid |
Completed |
Study Name: Efficacy of Ambrisentan in Limited Scleroderma Patients in Improving Blood Flow to Hands or Feet Condition: Ischemia Date: 2010-02-19 Interventions: Drug: ambrisentan Subjects will receive ambrisentan 5 mg orally once daily or identical placebo pills fo |
Completed |
Study Name: Digital Ischemic Lesions in Scleroderma Treated With Oral Treprostinil Diethanolamine Condition: Systemic Sclerosis Scleroderma Date: 2008-10-17 Interventions: Drug: treprostinil diethanolamine |